MARATTO

article · PLoS Medicine

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

202411 citationsOpen accessUniversité d'Abomey-Calavi

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

ClinicalTrials.gov NCT04303507; ISRCTN Registry ISRCTN10207947.

Research topics

  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1371/journal.pmed.1004428

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.